WallStreetZenWallStreetZen

NASDAQ: ASRT
Assertio Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ASRT

Based on 1 analyst offering 12 month price targets for Assertio Holdings Inc

Min Forecast
$3.50+380.11%
Avg Forecast
$3.50+380.11%
Max Forecast
$3.50+380.11%

Should I buy or sell ASRT stock?

Based on 1 analyst offering ratings for Assertio Holdings Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ASRT stock forecasts and price targets.

ASRT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-19

1 of 1

Forecast return on equity

Is ASRT forecast to generate an efficient return?

Company
0.88%
Industry
24.16%
Market
-15.81%
ASRT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ASRT forecast to generate an efficient return on assets?

Company
0.33%
Industry
11.79%
ASRT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ASRT earnings per share forecast

What is ASRT's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.27
Avg 2 year Forecast
$0.01

ASRT revenue forecast

What is ASRT's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$117.8M-1%
Avg 2 year Forecast
$135.6M+13.95%
ASRT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ASRT revenue growth forecast

How is ASRT forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
-1%
Industry
2.91%
Market
121.72%
ASRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ASRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ASRT vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ASRT$0.73$3.50+380.11%Buy
INCR$1.50N/AN/A
CRDL$0.99$9.00+812.78%Buy
DRRX$1.87N/AN/A
BGM$7.70N/AN/A
View Top Pharmaceutical Stocks

Assertio Holdings Stock Forecast FAQ

Is Assertio Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ASRT) stock is to Buy ASRT stock.

Out of 1 analyst, 0 (0%) are recommending ASRT as a Strong Buy, 1 (100%) are recommending ASRT as a Buy, 0 (0%) are recommending ASRT as a Hold, 0 (0%) are recommending ASRT as a Sell, and 0 (0%) are recommending ASRT as a Strong Sell.

If you're new to stock investing, here's how to buy Assertio Holdings stock.

What is ASRT's earnings growth forecast for 2025-2026?

(NASDAQ: ASRT) Assertio Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 200.38%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 55.31%.

Assertio Holdings's earnings in 2025 is -$30,612,000.On average, 1 Wall Street analyst forecast ASRT's earnings for 2025 to be -$25,860,800, with the lowest ASRT earnings forecast at -$25,860,800, and the highest ASRT earnings forecast at -$25,860,800.

In 2026, ASRT is forecast to generate $957,807 in earnings, with the lowest earnings forecast at $957,807 and the highest earnings forecast at $957,807.

What is ASRT's revenue growth forecast for 2025-2026?

(NASDAQ: ASRT) Assertio Holdings's forecast annual revenue growth rate of -1% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 2.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 121.72%.

Assertio Holdings's revenue in 2025 is $119,001,000.On average, 1 Wall Street analysts forecast ASRT's revenue for 2025 to be $11,283,929,097, with the lowest ASRT revenue forecast at $11,283,929,097, and the highest ASRT revenue forecast at $11,283,929,097.

In 2026, ASRT is forecast to generate $12,987,868,480 in revenue, with the lowest revenue forecast at $12,987,868,480 and the highest revenue forecast at $12,987,868,480.

What is ASRT's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ASRT) forecast ROA is 0.33%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 11.79%.

What is ASRT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ASRT price target, the average ASRT price target is $3.50, with the highest ASRT stock price forecast at $3.50 and the lowest ASRT stock price forecast at $3.50.

The Wall Street analyst predicted that Assertio Holdings's share price could reach $3.50 by May 19, 2026. The average Assertio Holdings stock price prediction forecasts a potential upside of 380.11% from the current ASRT share price of $0.73.

What is ASRT's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ASRT) Assertio Holdings's current Earnings Per Share (EPS) is -$0.32. On average, analysts forecast that ASRT's EPS will be -$0.27 for 2025, with the lowest EPS forecast at -$0.27, and the highest EPS forecast at -$0.27. In 2026, ASRT's EPS is forecast to hit $0.01 (min: $0.01, max: $0.01).

What is ASRT's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ASRT) forecast ROE is 0.88%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.